000 01779 a2200469 4500
005 20250513153722.0
264 0 _c19981102
008 199811s 0 0 eng d
022 _a0161-6420
024 7 _a10.1016/s0161-6420(98)91045-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStrohmaier, K
245 0 0 _aThe efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group.
_h[electronic resource]
260 _bOphthalmology
_cOct 1998
300 _a1936-44 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic beta-Antagonists
_xadministration & dosage
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCarbonic Anhydrase Inhibitors
_xadministration & dosage
650 0 4 _aDouble-Blind Method
650 0 4 _aDrug Administration Schedule
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aGlaucoma, Open-Angle
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aIntraocular Pressure
_xdrug effects
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOcular Hypertension
_xdrug therapy
650 0 4 _aOphthalmic Solutions
650 0 4 _aSafety
650 0 4 _aSulfonamides
_xadministration & dosage
650 0 4 _aThiophenes
_xadministration & dosage
650 0 4 _aTimolol
_xadministration & dosage
700 1 _aSnyder, E
700 1 _aDuBiner, H
700 1 _aAdamsons, I
773 0 _tOphthalmology
_gvol. 105
_gno. 10
_gp. 1936-44
856 4 0 _uhttps://doi.org/10.1016/s0161-6420(98)91045-4
_zAvailable from publisher's website
999 _c9751901
_d9751901